Evidence map›Paper›PMID 29290971›Full record

ArticleOncotarget2017

TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex.

Chen Luo, Rongfa Yuan, Leifeng Chen, Wei Zhou, Wei Shen, Yumin Qiu, Jun Shao, Jinlong Yan, Jianghua Shao

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. PIM1 kinase and its diverse substrate in solid tumors.Cell communication and signaling : CCS · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway.International journal of biological sciences · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Chen LuoDepartment of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Rongfa YuanDepartment of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Leifeng ChenDepartment of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Wei ZhouDepartment of Gastrointestinal Surgery, Jiangxi Provincial Cancer Hospital, Nanchang 330029, China.
Wei ShenDepartment of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Yumin QiuDepartment of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Jun ShaoDepartment of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Jinlong YanDepartment of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Jianghua ShaoDepartment of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Second Affiliated Hospital of Nanchang University · CNNanchang University · CNJiangxi Provincial Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor-β-activated kinase 1 (TAK1)-binding protein 3 (TAB3) is involved in cancer proliferation and metastasis, but its role in colorectal cancer remains unclear. In this study, we demonstrated that TAB3 is upregulated in colorectal cancer tissues and that high TAB3 levels correlated with tumor metastasis and a poor prognosis in colorectal cancer. In addition, TAB3 knockdown decreased Survivin expression and suppressed colorectal cancer cell migration and invasion

Indexed as

colorectal cancermetastasisNF-κB pathwaySurvivinTAB3

Identifiers

PMID29290971
PMCPMC5739756
OpenAlexW2770865142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.